Receive our newsletter – data, insights and analysis delivered to you
  1. News
September 28, 2017updated 23 Oct 2017 12:30pm

New research validates King’s College London’s new blood test for heart attacks

A new research funded by the British Heart Foundation (BHF) in the UK has validated that a new blood test developed by King’s College London could help to diagnose heart attacks more quickly.

A new research funded by the British Heart Foundation (BHF) in the UK has validated that a new blood test developed by King’s College London could help to diagnose heart attacks more quickly.

The blood test is designed to measure levels of troponin protein, while it is expected to speed up the discharge of patients from hospital and save the country’s National Health Service (NHS) millions of pounds every year.

The test analyses the rising levels of cardiac myosin-binding protein C (cMyC), which is reported to rise in the blood to a higher extent than troponin, following a heart attack.

British Heart Foundation medical director professor Nilesh Samani said: “These initial results with the cMyC test look very promising for patients, who could be more quickly diagnosed and treated, or reassured and sent home.

“This test could also allow hospitals to save hundreds of thousands of pounds by freeing up valuable hospital beds.”

Testing carried out across Europe showed that the blood test is quicker than a standard ECG test and can rule out a heart attack in more individuals.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment
“This test is not only just as good as the current test for working out who has had a heart attack, but it’s also much better at working out who hasn’t.”

The researchers said that further study is needed before the new test can be recommended as an alternative for existing troponin tests, which only measure the levels of troponin in the blood.

Kings College London Cardiology professor Mike Marber said: “We’ve shown that this test is not only just as good as the current test for working out who has had a heart attack, but it’s also much better at working out who hasn’t.

“We would love to see this new test rolled out in hospitals in the next five years.”

Marber led the new test’s cMyC project and received the first BHF Translational Research Grant for the project.


Image: Professor Mike Marber in his lab at King’s College London, UK. Photo: courtesy of the British Heart Foundation.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU